“…Impaired gut microbiota (dysbiosis), alterations in the richness and diversity of microbiota, leads to the pathophysiological processes of various diseases in humans and animals [ 20 , 21 , 22 , 23 , 24 ]. The modulation of the gut microbiota by the administration of probiotics, as well as prebiotics and synbiotics, has become a biotherapy strategy for preventing and treating many diseases, from stress-related irritable bowel syndrome to neuropsychiatric disorders [ 25 , 26 , 27 ]. Probiotics (direct-fed microbials) can restore the ecologic stability of gut microbiota by inhibiting pathogens, promoting the growth of beneficial bacteria, and releasing bioactive and immunomodulatory factors to improve the function of the hypothalamic–pituitary–adrenal axis (one of the major stress response systems) and immunity via the microbiota–gut–brain axis and or the microbiota–gut–immune axis [ 28 , 29 ].…”